Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Simina Ticau, Emre Aldinc, Michael Polydefkis, David Adams, Teresa Coelho, Mitsuharu Ueda, Cecilia Hale, John Vest & Paul Nioi. (2023) Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study. Amyloid 0:0, pages 1-11.
Read now
Read now
Alan Baltazar Treviño-Herrera, Ana Patricia Bustamante-Vargas, Andrés Lisker-Cervantes, Dolores Ríos Y Valles Valles, Cristina Villanueva-Mendoza, Alejandra González-Duarte & Luz Elena Concha-Del-Río. (2022) Vitreous involvement as initial presentation of hereditary transthyretin amyloidosis related to the rare TTR Ile107Met (p.Ile127Met) pathogenic variant. Ophthalmic Genetics 43:3, pages 413-419.
Read now
Read now
Massimo Russo, Laura Obici, Ilaria Bartolomei, Francesco Cappelli, Marco Luigetti, Silvia Fenu, Tiziana Cavallaro, Maria Grazia Chiappini, Chiara Gemelli, Luca Guglielmo Pradotto, Fiore Manganelli, Luca Leonardi, Filomena My, Simone Sampaolo, Chiara Briani, Luca Gentile, Claudia Stancanelli, Eleonora Di Buduo, Paolo Pacciolla, Fabrizio Salvi, Silvia Casagrande, Giulia Bisogni, Daniela Calabrese, Fiammetta Vanoli, Giuseppe Di Iorio, Giovanni Antonini, Lucio Santoro, Alessandro Mauro, Marina Grandis, Marco Di Girolamo, Gian Maria Fabrizi, Davide Pareyson, Mario Sabatelli, Federico Perfetto, Claudio Rapezzi, Giampaolo Merlini, Anna Mazzeo & Giuseppe Vita. (2020) ATTRv amyloidosis Italian Registry: clinical and epidemiological data. Amyloid 27:4, pages 259-265.
Read now
Read now
Eugenia Cisneros-Barroso, Juan González-Moreno, Adrian Rodríguez, Tomas Ripoll-Vera, Jorge Álvarez, Mercedes Usón, Antonio Figuerola, Cristina Descals, Carles Montalá, Maria Asunción Ferrer-Nadal & Ines Losada. (2020) Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster. Amyloid 27:4, pages 254-258.
Read now
Read now
Marcia Waddington-Cruz, Elizabeth J. Ackermann, Michael Polydefkis, Stephen B. Heitner, Peter J. Dyck, Fabio A. Barroso, Annabel K. Wang, John L. Berk, P. James B. Dyck, Brett P. Monia, Steven G. Hughes, Li Tai, T. Jesse Kwoh, Shiangtung W. Jung, Teresa Coelho, Merrill D. Benson & Morie A. Gertz. (2018) Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial. Amyloid 25:3, pages 180-188.
Read now
Read now
David Adams, Cecile Cauquil, Céline Labeyrie, Guillemette Beaudonnet, Vincent Algalarrondo & Marie Théaudin. (2016) TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies. Expert Opinion on Pharmacotherapy 17:6, pages 791-802.
Read now
Read now
Philip N. Hawkins, Yukio Ando, Angela Dispenzeri, Alejandra Gonzalez-Duarte, David Adams & Ole B. Suhr. (2015) Evolving landscape in the management of transthyretin amyloidosis. Annals of Medicine 47:8, pages 625-638.
Read now
Read now
Marie Théaudin, Cécile Cauquil, Teresa Antonini, Vincent Algalarrondo, Céline Labeyrie, Sophie Aycaguer, Mireille Clément, Marie Kubezyk, Géraldine Nonnez, Agnès Morier, Catherine Bourges, Amandine Darras, Laurence Mouzat & David Adams. (2014) Familial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, “EdAmyl”. Amyloid 21:4, pages 225-230.
Read now
Read now
David Adams, Cecile Cauquil, Marie Theaudin, Antoine Rousseau, Vincent Algalarrondo & Michel S Slama. (2014) Current and future treatment of amyloid neuropathies. Expert Review of Neurotherapeutics 14:12, pages 1437-1451.
Read now
Read now
Pierre Lozeron, Catherine Lacroix, Marie Theaudin, Anne Richer, Michel Gugenheim, David Adams & Micheline Misrahi. (2013) An amyotrophic lateral sclerosis-like syndrome revealing an amyloid polyneuropathy associated with a novel transthyretin mutation. Amyloid 20:3, pages 188-192.
Read now
Read now
Articles from other publishers (53)
Yukio Ando, Marcia Waddington-Cruz, Yoshiki Sekijima, Haruki Koike, Mitsuharu Ueda, Hiroaki Konishi, Tomonori Ishii & Teresa Coelho. (2023) Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Kazuna Ikeda, Daisuke Yamamoto, Keiko Usui, Hiroki Takeuchi, Nobuyuki Oka, Nagaaki Katoh, Masahide Yazaki, Fuyuki Kametani, Ichizo Nishino & Shin Hisahara. (2023) Transthyretin Variant Amyloidosis with a <i>TTR</i> A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy. Internal Medicine 62:15, pages 2261-2266.
Crossref
Crossref
Valentin Loser, Pascal Benkert, Alex Vicino, Pansy Lim Dubois Ferriere, Thierry Kuntzer, Jérôme Pasquier, Aleksandra Maceski, Jens Kuhle & Marie Theaudin. (2022) Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience. Journal of the Peripheral Nervous System 28:1, pages 86-97.
Crossref
Crossref
Marcus Vinicius Pinto, Marcondes Cavalcante FrançaJrJr, Marcus Vinicius Magno Gonçalves, Marcela Câmara Machado-Costa, Marcos Raimundo Gomes de Freitas, Francisco de Assis Aquino Gondim, Carlo Domenico Marrone, Alberto Rolim Muro Martinez, Carolina Lavigne Moreira, Osvaldo J. M. Nascimento, Anna Paula Paranhos Covaleski, Acary Souza Bulle de Oliveira, Camila Castelo Branco Pupe, Marcia Maria Jardim Rodrigues, Francisco Tellechea Rotta, Rosana Herminia Scola, Wilson MarquesJrJr & Márcia Waddington-Cruz. (2023) Brazilian consensus for diagnosis, management and treatment of hereditary transthyretin amyloidosis with peripheral neuropathy: second edition. Arquivos de Neuro-Psiquiatria 81:03, pages 308-321.
Crossref
Crossref
M. Masingue, G. Fernández-Eulate, R. Debs, C. Tard, C. Labeyrie, S. Leonard-Louis, C.-M. Dhaenens, M.A. Masson, P. Latour & T. Stojkovic. (2023) Strategy for genetic analysis in hereditary neuropathy. Revue Neurologique 179:1-2, pages 10-29.
Crossref
Crossref
Osvaldo J. M. Nascimento, Wilson MarquesJrJr, Pedro Tomaselli & Carolina Lavigne-Moreira. 2023. Amyloidosis and Fabry Disease. Amyloidosis and Fabry Disease
5
17
.
Justine Solignac, Emilien Delmont, Etienne Fortanier, Shahram Attarian, Julien Mancini, Laurent Daniel, Ioana Ion, Jean-Etienne Ricci, Thomas Robert, Gilbert Habib, Olivier Moranne & Noémie Jourde-Chiche. (2022) Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients. Clinical Kidney Journal 15:9, pages 1747-1754.
Crossref
Crossref
A.-L. Kaminsky & J.-P. Camdessanché. (2022) Neuropatie sensitive. EMC - Neurologia 22:1, pages 1-7.
Crossref
Crossref
V.A. Feitosa, P.D.M.M. Neves, L.B. Jorge, I.L. Noronha & L.F. Onuchic. (2022) Renal amyloidosis: a new time for a complete diagnosis. Brazilian Journal of Medical and Biological Research 55.
Crossref
Crossref
S. S. Nikitin, S. N. Bardakov, N. A. Suponeva, I. V. Zhirov, T. A. Adyan, D. A. Grishina & R. V. Deev. (2021) Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy. Neuromuscular Diseases 11:3, pages 12-36.
Crossref
Crossref
David Adams, Vincent Algalarrondo, Michael Polydefkis, Nitasha Sarswat, Michel S. Slama & Jose Nativi-Nicolau. (2021) Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Montserrat Vera-Llonch, Sheila R. Reddy, Eunice Chang, Marian H. Tarbox & Michael Pollock. (2021) The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Georgios Koutsis, Efstathios Kastritis, Zoi Kontogeorgiou, Chrisoula Kartanou, Panagiotis Kokotis, Michail Rentzos, Marianthi Breza, Kleopas A. Kleopa, Kyproula Christodoulou, Evangelos Oikonomou, Aris Anastasakis, Panagiotis Angelidakis, Ioannis Sarmas, Odysseas Kargiotis, Minas Tzagournissakis, Ioannis Zaganas, Emmanouil Foukarakis, Vasileios Sachpekidis, Alexandra Papathoma, Marios Panas, Leonidas Stefanis, Meletios Athanasios Dimopoulos & Georgia Karadima. (2021) Variant transthyretin amyloidosis (ATTRv) polyneuropathy in Greece: a broad overview with a focus on non-endemic unexplored regions of the country. Neuromuscular Disorders 31:12, pages 1251-1258.
Crossref
Crossref
Pranav Chandrashekar, Laith Alhuneafat, Meghan MannelloLana Al-Rashdan, Morris M. Kim, Jason Dungu, Kevin Alexander & Ahmad Masri. (2021)
Prevalence and Outcomes of p.Val142Ile
TTR
Amyloidosis Cardiomyopathy: A Systematic Review
. Circulation: Genomic and Precision Medicine 14:5.
Crossref
Crossref
David Adams, Yukio Ando, João Melo Beirão, Teresa Coelho, Morie A. Gertz, Julian D. Gillmore, Philip N. Hawkins, Isabelle Lousada, Ole B. Suhr & Giampaolo Merlini. (2020) Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. Journal of Neurology 268:6, pages 2109-2122.
Crossref
Crossref
Radislav Nakov, Ole B. Suhr, Gianluca Ianiro, Juozas Kupcinskas, Jonathon P. Segal, Dan L. Dumitrascu, Henriette Heinrich, Ivana Mikolasevic, Milica Stojkovic-Lalosevic, Ivan Barbov, Stayko Sarafov, Ivailo Tournev, Ventsislav Nakov & Jonas Wixner. (2020) Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations. European Journal of Gastroenterology & Hepatology 33:5, pages 613-622.
Crossref
Crossref
Morie Gertz, David Adams, Yukio Ando, João Melo Beirão, Sabahat Bokhari, Teresa Coelho, Raymond L. Comenzo, Thibaud Damy, Sharmila Dorbala, Brian M. Drachman, Marianna Fontana, Julian D. Gillmore, Martha Grogan, Philip N. Hawkins, Isabelle Lousada, Arnt V. Kristen, Frederick L. Ruberg, Ole B. Suhr, Mathew S. Maurer, Jose Nativi-Nicolau, Candida Cristina Quarta, Claudio Rapezzi, Ronald Witteles & Giampaolo Merlini. (2020) Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Family Practice 21:1.
Crossref
Crossref
Roxane Bunod, David Adams, Cécile Cauquil, Bruno Francou, Céline Labeyrie, Halima Bourenane, Clovis Adam, Vincent Algalarrondo, Michel Slama, Martha Darce-Bello, Emmanuel Barreau, Marc Labetoulle & Antoine Rousseau. (2020) Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis. British Journal of Ophthalmology 104:10, pages 1363-1367.
Crossref
Crossref
Radislav Nakov, Stayko Sarafov, Mariana Gospodinova, Andrey Kirov, Teodora Chamova, Tihomir Todorov, Albena Todorova & Ivailo Tournev. (2020) Transthyretin amyloidosis: Testing strategies and model for center of excellence support. Clinica Chimica Acta 509, pages 228-234.
Crossref
Crossref
Laura Obici & David Adams. (2020) Acquired and inherited amyloidosis: Knowledge driving patients' care. Journal of the Peripheral Nervous System 25:2, pages 85-101.
Crossref
Crossref
E. Fortanier, E. Delmont, A Verschueren & S. Attarian. (2020) Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy. Clinical Neurophysiology 131:5, pages 1129-1133.
Crossref
Crossref
Gabriel GianniniCynthia C. Nast. (2019) An Organ System–Based Approach to Differential Diagnosis of Amyloid Type in Surgical Pathology. Archives of Pathology & Laboratory Medicine 144:3, pages 379-387.
Crossref
Crossref
David Adams, Haruki Koike, Michel Slama & Teresa Coelho. (2019) Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nature Reviews Neurology 15:7, pages 387-404.
Crossref
Crossref
Armindo Fernandes, Teresa Coelho, Aurora Rodrigues, Helena Felgueiras, Pedro Oliveira, António Guimarães, Manuel Melo-Pires & Ricardo Taipa. (2019) Clinicopathological correlations of sural nerve biopsies in TTR Val30Met familial amyloid polyneuropathy. Brain Communications 1:1.
Crossref
Crossref
Yoshiki Sekijima, Mitsuharu Ueda, Haruki Koike, Sonoko Misawa, Tomonori Ishii & Yukio Ando. (2018) Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Marcus Vinicius Pinto, Amilton Antunes Barreira, Acary Souza Bulle, Marcos Raimundo Gomes de Freitas, Marcondes Cavalcante França Jr, Francisco de Assis Aquino Gondim, Carlo Domenico Marrone, Wilson Marques Jr, Osvaldo J. M. Nascimento, Francisco Tellechea Rotta, Camila Pupe & Márcia Waddington-Cruz. (2018) Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy. Arquivos de Neuro-Psiquiatria 76:9, pages 609-621.
Crossref
Crossref
Pierre LozeronLouise-Laure MarianiPauline DodetGuillemette BeaudonnetMarie ThéaudinClovis AdamBertrand ArnulfDavid Adams. (2018) Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy. Neurology 91:2.
Crossref
Crossref
Andrea Iorio, Flavio De Angelis, Marco Di Girolamo, Marco Luigetti, Luca G. Pradotto, Anna Mazzeo, Sabrina Frusconi, Filomena My, Dario Manfellotto, Maria Fuciarelli & Renato Polimanti. (2017) Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis. BMC Genomics 18:1.
Crossref
Crossref
David Adams, Cécile Cauquil & Céline Labeyrie. (2017) Familial amyloid polyneuropathy. Current Opinion in Neurology 30:5, pages 481-489.
Crossref
Crossref
Haruki KoikeShohei IkedaMie TakahashiYuichi KawagashiraMasahiro IijimaYohei MisumiYukio AndoShu-ichi IkedaMasahisa KatsunoGen Sobue. (2016) Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy. Neurology 87:21, pages 2220-2229.
Crossref
Crossref
Yusuf A Rajabally, David Adams, Philippe Latour & Shahram Attarian. (2016) Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses. Journal of Neurology, Neurosurgery & Psychiatry 87:10, pages 1051-1060.
Crossref
Crossref
D. Adams, G. Beaudonnet, C. Adam, C. Lacroix, M. Théaudin, C. Cauquil & C. Labeyrie. (2016) Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?. Revue Neurologique 172:10, pages 645-652.
Crossref
Crossref
Teresa Coelho, Giampaolo Merlini, Christine E. Bulawa, James A. Fleming, Daniel P. Judge, Jeffery W. Kelly, Mathew S. Maurer, Violaine Planté-Bordeneuve, Richard Labaudinière, Rajiv Mundayat, Steve Riley, Ilise Lombardo & Pedro Huertas. (2016) Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis. Neurology and Therapy 5:1, pages 1-25.
Crossref
Crossref
Laura Obici, Jan B. Kuks, Juan Buades, David Adams, Ole B. Suhr, Teresa Coelho & Theodore Kyriakides. (2016) Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis. Current Opinion in Neurology 29:Supplement 1, pages S27-S35.
Crossref
Crossref
David Adams, Ole B. Suhr, Ernst Hund, Laura Obici, Ivailo Tournev, Josep M. Campistol, Michel S. Slama, Bouke P. Hazenberg & Teresa Coelho. (2016) First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Current Opinion in Neurology 29:Supplement 1, pages S14-S26.
Crossref
Crossref
Yesim Parman, David Adams, Laura Obici, Lucía Galán, Velina Guergueltcheva, Ole B. Suhr & Teresa Coelho. (2016) Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe. Current Opinion in Neurology 29:Supplement 1, pages S3-S13.
Crossref
Crossref
Morie A. Gertz, Merrill D. Benson, Peter J. Dyck, Martha Grogan, Terresa Coelho, Marcia Cruz, John L. Berk, Violaine Plante-Bordeneuve, Hartmut H.J. Schmidt & Giampaolo Merlini. (2015) Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. Journal of the American College of Cardiology 66:21, pages 2451-2466.
Crossref
Crossref
Louise‐Laure MarianiPierre Lozeron, Marie Théaudin, Zoia Mincheva, Aissatou Signate, Beatrice Ducot, Vincent Algalarrondo, Christian Denier, Clovis Adam, Guillaume Nicolas, Didier Samuel, Michel S. Slama, Catherine Lacroix, Micheline Misrahi & David Adams. (2015) Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France. Annals of Neurology 78:6, pages 901-916.
Crossref
Crossref
David AdamsTeresa CoelhoLaura ObiciGiampaolo MerliniZoia MinchevaNarupat SuanprasertBrian R. BettencourtJared A. GollobPritesh J. GandhiWilliam J. LitchyPeter J. Dyck. (2015) Rapid progression of familial amyloidotic polyneuropathy. Neurology 85:8, pages 675-682.
Crossref
Crossref
Anna Mazzeo, Massimo Russo, Gianluca Di Bella, Fabio Minutoli, Claudia Stancanelli, Luca Gentile, Sergio Baldari, Scipione Carerj, Antonio Toscano & Giuseppe Vita. (2015) Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area. Journal of Neuromuscular Diseases 2:s2, pages S39-S48.
Crossref
Crossref
Carolina Lavigne Moreira, Vanessa D. Marques, Charles M. Lourenço, Daisy I. Cabrini, Jose C. Nuñez, Ronaldo F. Herrera & Wilson MarquesJrJr. (2015) Transthyretin Asp38Tyr: a new mutation associated to a late onset neuropathy. Journal of the Peripheral Nervous System 20:1, pages 60-62.
Crossref
Crossref
E. Hund. (2014) Hereditäre Transthyretin-AmyloidosenHereditary transthyretin amyloidosis. Der Nervenarzt 85:10, pages 1291-1297.
Crossref
Crossref
H. Koike & G. Sobue. (2013) What is the prototype of familial amyloid polyneuropathy?. Journal of Neurology, Neurosurgery & Psychiatry 85:7, pages 713-713.
Crossref
Crossref
David Adams, Pierre Lozeron & Vincent Algalarrondo. (2014) Utilisation de l’ARN interférence dans le traitement de l’amylose héréditaire due à une mutation de la transthyrétine. médecine/sciences 30:4, pages 345-347.
Crossref
Crossref
David Adams, Marie Théaudin, Cecile Cauquil, Vincent Algalarrondo & Michel Slama. (2014) FAP Neuropathy and Emerging Treatments. Current Neurology and Neuroscience Reports 14:3.
Crossref
Crossref
P. Lozeron, M. Théaudin, Z. Mincheva, B. Ducot, C. Lacroix & D. Adams. (2013) Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy. European Journal of Neurology 20:12, pages 1539-1545.
Crossref
Crossref
E. Delmont & C. Desnuelle. (2013) Investigations complémentaires devant une neuropathie périphérique. Pratique Neurologique - FMC 4:4, pages 233-239.
Crossref
Crossref
A. Lacour. (2013) Actualités dans les neuropathies héréditaires. Revue Neurologique 169:12, pages 1001-1003.
Crossref
Crossref
David Adams. (2012) Recent advances in the treatment of familial amyloid polyneuropathy. Therapeutic Advances in Neurological Disorders 6:2, pages 129-139.
Crossref
Crossref
Massimo Russo, Anna Mazzeo, Claudia Stancanelli, Rita Di Leo, Luca Gentile, Gianluca Di Bella, Fabio Minutoli, Sergio Baldari & Giuseppe Vita. (2012) Transthyretin‐related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. Journal of the Peripheral Nervous System 17:4, pages 385-390.
Crossref
Crossref
David Adams, Pierre Lozeron & Catherine Lacroix. (2012) Amyloid neuropathies. Current Opinion in Neurology 25:5, pages 564-572.
Crossref
Crossref
David Adams, Cécile Cauquil & Marie Théaudin. (2012) Neuropathies amyloïdes héréditaires : aspects thérapeutiques. Bulletin de l'Académie Nationale de Médecine 196:7, pages 1333-1347.
Crossref
Crossref
Jean-Michel Vallat, Benoît Funalot, Frédéric Faugeras & Laurent Magy. (2012) Neuropathies amyloïdes héréditaires : aspects cliniques et neuropathologiques. Bulletin de l'Académie Nationale de Médecine 196:7, pages 1321-1331.
Crossref
Crossref